Who’s Hired? mAbxience Appoints A New CEO
While Biosimilars Canada Re-Elects Leaders And Lupin Adds Two Independent Directors
Spain’s mAbxience has named a new CEO following the departure of former chief Emanuelle Lepine. Meanwhile, Biosimilars Canada has re-elected its chair and vice-chair, while Lupin has added a pair of independent directors to its board.
